About the Androgenetic Alopecia Session
Androgenetic alopecia, commonly known as male or female pattern baldness, is a hereditary condition characterized by progressive hair loss. This condition affects both genders, typically starting with a receding hairline or thinning at the crown in men, while women usually experience diffuse thinning across the scalp. The underlying cause involves the action of androgens, particularly dihydrotestosterone (DHT), which shrinks hair follicles and shortens the hair growth cycle.
In dermatology and cosmetology, various treatment options are available, including topical minoxidil, oral finasteride, and low-level laser therapy. Advanced techniques like platelet-rich plasma (PRP) therapy and hair transplantation are also gaining popularity. A comprehensive approach, including lifestyle modifications and proper scalp care, can enhance treatment effectiveness, making it essential for individuals to consult with specialists for personalized solutions.
Featured Speakers — Androgenetic Alopecia 2027
Speaker lineup for this track will be announced soon.
Browse all speakers →Recent Research Presented at Androgenetic Alopecia Sessions
Selected abstracts from this track will be published here.
Related Scientific Sessions at IDC 2027
Why Attend the Androgenetic Alopecia Conference 2027
Present Your Research
Oral and poster slots for original Androgenetic Alopecia work, reviewed by the scientific committee.
Network Globally
Meet researchers, clinicians, and industry leaders from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Androgenetic Alopecia research and practice.
Hybrid Flexibility
Attend in person in Rome or join virtually — same program, same certificate.
Join IDC 2027 for the Androgenetic Alopecia track
Oral and poster slots for your work — in person in Rome or online. Not presenting? Attend as a delegate to learn from the field.
Androgenetic Alopecia Conference 2027 — FAQs
What is the Androgenetic Alopecia track at IDC 2027?
The Androgenetic Alopecia track is a dedicated stream within IDC 2027 covering the latest research, clinical innovation, and best practice in Androgenetic Alopecia. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Androgenetic Alopecia sessions?
Researchers, clinicians, educators, doctoral students, and industry leaders with an interest in Androgenetic Alopecia are all welcome — whether presenting or attending.
Can I present my research in the Androgenetic Alopecia track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Androgenetic Alopecia sessions?
Yes. IDC 2027 is a hybrid conference — attend the Androgenetic Alopecia track in person in Rome or join live online, with on-demand access afterward.
Join the IDC 2027 delegation
Rome · June 21–23, 2027 · Hybrid · in-person & virtual
Attend without presenting.

